Kingsview Wealth Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1791965
GRANTS PASS, OR
Position in REGN
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$570,980
-$55,006 QoQ
Shares Held
739
-8.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kingsview Wealth Management, LLC holds $3,730,947 across 13 Biotechnology names. REGN ranks #3 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VKTX |
Viking Therapeutics, Inc.
|
21,975 | $715,066 | |
| 2 | IMRX |
Immuneering Corp
|
122,200 | $643,994 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
739 | $570,980 | |
| 4 | INSM |
INSMED Inc
|
2,089 | $341,593 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
1,806 | $305,250 | |
| 6 | INCY |
Incyte Corp
|
3,134 | $294,972 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
545 | $243,364 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
15,770 | $188,136 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $570,980 | 739 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $625,986 | 811 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $438,570 | 780 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $476,700 | 908 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $575,880 | 908 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $713,754 | 1,002 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $904,066 | 860 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $880,763 | 838 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $773,841 | 804 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $706,145 | 804 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $653,430 | 794 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $492,918 | 686 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $564,487 | 687 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $510,814 | 708 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $566,251 | 822 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $432,116 | 731 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $495,179 | 709 | Shares | Sole | 2024-02-08 | |
| 2021-12-31 | $436,380 | 691 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $493,826 | 816 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $391,536 | 701 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $308,014 | 651 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $303,393 | 628 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $556,981 | 995 | Shares | Sole | 2020-11-19 | |
| 2020-06-30 | $636,123 | 1,020 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $528,329 | 1,082 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||